Fundraising FoxMimetogen
Montreal, CA · 1 known investors
Find your way into Mimetogen
Sign up to see every warm intro you have to Mimetogen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mimetogen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Mimetogen is a biotechnology company developing novel therapeutics, with a focus on tavilermide for ophthalmic indications including dry eye disease. The company brings together expertise in drug discovery, development, and clinical research to advance treatment options in ophthalmology.
Founders & leadership
DB
Dr. BrazzellChief Medical Officer
Board
KG
Kevin GieseExecutive Chairman of the Board
SA
Steven A. PeposeChief Medical Advisor
Investors · 1
Frequently asked questions
- What does Mimetogen do?
- Mimetogen is a biotechnology company developing novel therapeutics, with a focus on tavilermide for ophthalmic indications including dry eye disease. The company brings together expertise in drug discovery, development, and clinical research to advance treatment options in ophthalmology.
- Who are Mimetogen's investors?
- Mimetogen's investors include Schooner Capital.
- Where is Mimetogen headquartered?
- Mimetogen is headquartered in Montreal, CA.